1. Home
  2. PFE

PFE

Pfizer Inc.

Logo Pfizer Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 11:30am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Founded: 1849 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 146.7B IPO Year: N/A
Target Price: $36.88 AVG Volume (30 days): 42.9M
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield: 6.63% Dividend Payout Frequency: Quarterly
EPS: 0.37 EPS Growth: -93.24
52 Week Low/High: $25.61 - $41.71 Next Earning Date: 05-01-2024
Revenue: $58,496,000,000 Revenue Growth: -41.70%
Revenue Growth (this year): 3.59% Revenue Growth (next year): 4.88%

Share on Social Networks: